Institute urges overhaul of US cancer trials networkBMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c2142 (Published 21 April 2010) Cite this as: BMJ 2010;340:c2142
- Bob Roehr
- 1Washington, DC
The large Clinical Trials Cooperative Group Program sponsored by the US National Cancer Institute has become “inefficient and cumbersome,” says a report from the Institute of Medicine. It needs to be “redesigned to improve value by reducing redundancy and improving effectiveness and efficacy of trials,” it says.
The cooperative group programme involves more than 3100 institutions, 14 000 investigators, and 25 000 patients in clinical trials each year. But it takes two years to plan and initiate a new trial; only about half are ever completed; and funding has fallen by 20% since 2002.
These changes have occurred while basic science has yielded …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial